Comprehensive staging surgery including complete pelvic and para-aortic lymphadenectomy followed by adjuvant vaginal brachytherapy improves survival rates for intermediate-risk endometrial cancer patients

Gynecologic and Obstetric Investigation

Volumn 74, Issue 1, 2012, Pages 68-75

  Kong, Tae Wook ^a   Paek, Jiheum ^a   Chang, Suk Joon ^a   Chun, Mison ^a   Chang, Ki Hong ^a   Ryu, Hee Sug ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adjuvant vaginal brachytherapy; Intermediate risk endometrial cancer; Surgical staging

Indexed keywords

ADNEXECTOMY; ADULT; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VAGINA;

EID: 84864586752     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000336771     Document Type: Article

References (40)

1. Morrow CP, Bundy BN, Kurman RJ, Creas-man WT, Heller P, Homesley HD, Graham JE: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gyne-col Oncol 1991; 40:55-65.
2. Fanning J: Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 2001; 82: 371-374.
3. Odagiri T, Watari H, Hosaka M, Mitamura T, Konno Y, Kato T, Kobayashi N, Sudo S, Takeda M, Kaneuchi M, Sakuragi N: Multi-variate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol 2011; 22:3-8.
4. Aalders J, Abeler V, Kolstad P, Onsrud M: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-427.
5. Creutzberg CL, van Putten WL, Koper PC, Ly-beert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter K A, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411.
6. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk en-dometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92:744-751.
7. MacLeod C, Fowler A, Duval P, D'Costa I, Dalrymple C, Firth I, Elliott P, Atkinson K, Carter J: High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 1998; 42: 1033-1039.
8. Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC: Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gy necol Ca ncer 1999; 9: 456-462.
9. Anderson JM, Stea B, Hallum AV, Rogoff E, Childers J: High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 2000; 46:417-425.
10. Horowitz NS, Peters WA, 3rd, Smith MR, Drescher CW, Atwood M, Mate TP: Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gy necol 2002; 99: 235-240.
11. Alektiar KM, Venkatraman E, Chi DS, Bara-kat RR: Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005; 62: 111-117.
12. Solhjem MC, Petersen IA, Haddock MG: Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endome-trial cancer. Int J Radiat Oncol Biol Phys 2005; 62: 1379-1384.
13. Cengiz M, Singh AK, Grigsby PW: Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer. Int J Gynecol Cancer 2005; 15:926-931.
14. Jolly S, Vargas C, Kumar T, Weiner S, Brab-bins D, Chen P, Floyd W, Martinez AA: Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 2005; 97:887-892.
15. Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW: External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007; 106:215-220.
16. Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL: Vaginal brachy-therapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised tria l. Lancet 2010; 375: 816-823.
17. Chan JK, Kapp DS: Role of complete lymph-adenectomy in endometrioid uterine cancer. Lancet Oncol 2007; 8: 831-841.
18. Gynecologic Oncology Group surgical procedures manual. 2007. http://www.gog.org.
19. Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometri-um. Int J Gynaecol Obstet 2009; 105:103-194.
20. Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK, Amos C, Murray C, Qian W: Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic rev iew, and meta-analysis. Lancet 2009; 373: 137-146.
21. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M: Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Post-Operative Radiation Therapy in Endometrial Carcinoma trial. J Clin Oncol 2004; 22:1234-1241.
22. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R: Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008; 108:226-233.
23. Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G, Colombo A, Fossati R: Adjuvant chemotherapy vs. radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95: 266-271.
24. Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP: Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50:1145-1153.
25. Watari H, Mitamura T, Moriwaki M, Hosaka M, Ohba Y, Sudo S, Todo Y, Takeda M, Ebina Y, Sakuragi N: Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy. Int J Gynecol Ca ncer 2009; 19: 1585-1590.
26. Chan JK, Urban R, Cheung MK, Shin JY, Hu-sain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K: Lymphadenectomy in endo-metrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer 2007; 109:2454-2460.
27. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL, Abu-Rustum NR: The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endome-trial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 2008; 18: 269-273.
28. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23: 3668-3675.
29. Geisler JP, Linnemeier GC, Manahan KJ: Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium. Int J Gynaecol Obstet 2007; 98:39-43.
30. Lutman CV, Havrilesky LJ, Cragun JM, Se-cord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT: Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102:92-97.
31. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC: Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-18.
32. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS: Therapeutic role of lymph node resection in endometri-oid corpus cancer: a study of 12,333 patients. Cancer 2006; 107:1823-1830.
33. Euscher ED, Bassett R, Malpica A: Lymph node counts in endometrial cancer: expectations versus reality. Am J Surg Pathol 2011; 35: 913-918.
34. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Spiegel G, Barakat R, Pearl ML, Sharma SK: Lap-aroscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009; 27:5331-5336.
35. Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS: Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann Surg Oncol 2010; 17: 3234-2340.
36. Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC: Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 2004; 199: 388-393.
37. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK: Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373: 125-136.
38. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Croce C, Mangioni C: Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707-1716.
39. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J: Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010:CD007585.
40. Chang SJ, Ryu HS: The role of lymphadenec-tomy in surgical staging of endometrial cancer. J Gynecol Oncol 2006; 17:6.